Evidence map›Paper›PMID 41180889›Full record

ArticleJAMIA open2025

Assessing the acceptability and usability of MedSafer, a patient-centered electronic deprescribing tool.

Jimin J Lee, Eva Filosa, Tiphaine Pierson, Ninh Khuong, Camille Gagnon, Jennie Herbin, Soham Rej, Claire Godard-Sebillotte, Robyn Tamblyn, Todd C Lee and 1 more

Abstract read
In one paragraph

Article in JAMIA open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jimin J LeeDivision of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H4A 3J1, Canada.ORCID https://orcid.org/0009-0008-3785-4452
Eva FilosaDivision of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H4A 3J1, Canada.
Tiphaine PiersonCanadian Medication Appropriateness and Deprescribing Network, Montréal, QC H3W 1W6, Canada.
Ninh KhuongCanadian Medication Appropriateness and Deprescribing Network, Montréal, QC H3W 1W6, Canada.
Camille GagnonCanadian Medication Appropriateness and Deprescribing Network, Montréal, QC H3W 1W6, Canada.
Jennie HerbinCanadian Medication Appropriateness and Deprescribing Network, Montréal, QC H3W 1W6, Canada.
Soham RejDepartment of Psychiatry, Lady Davis Institute/Jewish General Hospital, McGill University, Montréal, QC H3T 1E4, Canada.
Claire Godard-SebillotteDivision of Geriatrics, Department of Medicine, McGill University Health Centre, Montréal, QC H3T 1E2, Canada.
Robyn TamblynDepartment of Epidemiology and Biostatistics, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.
Todd C LeeDivision of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H4A 3J1, Canada.
Emily G McDonaldDivision of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H4A 3J1, Canada.ORCID https://orcid.org/0000-0003-0783-0624

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Deprescribing is the clinically supervised process of stopping or reducing medications that are no longer beneficial. MedSafer is an electronic decision support tool that guides healthcare providers (HCPs) through the deprescribing process. We recently developed a novel patient-facing version of the software, allowing patients and caregivers to generate a personalized deprescribing report to bring to their prescriber. Objective: The study aimed to evaluate the usability and acceptability of MedSafer among older adults, caregivers, and community HCPs (physicians, nurse practitioners and pharmacists). Method: A mixed-methods feasibility study was conducted with a convenience sample of 100 older adults/caregivers, and 25 healthcare practitioners. Participants were invited to test MedSafer and answer telephone or electronic surveys via RedCap. The Extended Technology Acceptance Model (TAM2) and System Usability Scale (SUS) were used for evaluation. A semi-structured interview was also conducted with a subset of participants (5 per group) who were selected on a volunteer basis, and thematic analysis was used following Braun & Clarke's approach. Results: Healthcare providers scored more favorably on TAM2 constructs such as perceived usefulness (PU) (median: 4.25 for HCPs; 3.75 for caregivers; 3.00 for patients), and SUS compared to patients and caregivers (mean: 79.50 for HCPs; 52.95 for caregivers; 55.75 for patients). Thematic analysis revealed that participants recognized MedSafer as an empowering tool but noted the need for some usability improvements. Conclusion: MedSafer is a promising tool to support deprescribing conversations. Enhancing usability, accessibility, and patient education may improve adoption.

Indexed as

decision supportdeprescribingdigital healthSUSTAM2

Identifiers

PMID41180889
PMCPMC12574792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.